RE: Reminders from Q&A24 Aug 2020 15:19
Just to highlight one point here. I haven't read the board much last week or so, but i doubt this is even been mentioned....
The Mologic lateral flow antibody test, for which currently 80% of the lateral flow capacity is available for, and a product that will be more profitable as Omega will deliver a packaged end product and not just the cassette like with UK RTC, is expected to be CE marked by the end of Aug.
So add this onto the UK RTC supply agreement and tech transfer etc, the development of the Antigen Elisa test completion all due any day, this is a huge 1-2 weeks.